Literature DB >> 32681167

Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis.

Paolo Delvino1, Alice Bartoletti1, Sara Monti1,2, Alessandro Biglia1, Carlomaurizio Montecucco1, Mauro Carducci3, Giorgio Ripamonti3, Lorenzo Cavagna1.   

Abstract

Entities:  

Year:  2020        PMID: 32681167     DOI: 10.1093/rheumatology/keaa377

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  2 in total

Review 1.  A glance into the future of myositis therapy.

Authors:  Ilaria Chiapparoli; Claudio Galluzzo; Carlo Salvarani; Nicolò Pipitone
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-24       Impact factor: 3.625

Review 2.  The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET.

Authors:  Rosaria Talarico; Silvia Aguilera; Tobias Alexander; Zahir Amoura; Ana M Antunes; Laurent Arnaud; Tadej Avcin; Lorenzo Beretta; Stefano Bombardieri; Gerd R Burmester; Sara Cannizzo; Lorenzo Cavagna; Benjamin Chaigne; Alain Cornet; Nathalie Costedoat-Chalumeau; Andrea Doria; Alessandro Ferraris; Rebecca Fischer-Betz; João E Fonseca; Charissa Frank; Andrea Gaglioti; Ilaria Galetti; Jürgen Grunert; Vera Guimarães; Eric Hachulla; Frederic Houssiau; Luca Iaccarino; Thomas Krieg; Marteen Limper; Fransiska Malfait; Xavier Mariette; Diana Marinello; Thierry Martin; Lisa Matthews; Marco Matucci-Cerinic; Alain Meyer; Carlomaurizio Montecucco; Luc Mouthon; Ulf Müller-Ladner; Simona Rednic; Vasco C Romão; Matthias Schneider; Vanessa Smith; Alberto Sulli; Farah Tamirou; Domenica Taruscio; Anna V Taulaigo; Enrique Terol; Angela Tincani; Simone Ticciati; Giuseppe Turchetti; P Martin van Hagen; Jacob M van Laar; Ana Vieira; Jeska K de Vries-Bouwstra; Maurizio Cutolo; Marta Mosca
Journal:  Nat Rev Rheumatol       Date:  2021-01-06       Impact factor: 32.286

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.